<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/ncpendmet/current_issue/rss">
<title>Nature Clinical Practice Endocrinology &amp; Metabolism</title>
<description>Nature Clinical Practice Endocrinology &amp; Metabolism provides physicians with authoritative and timely interpretations of key developments in the field, translating the latest findings into clinical practice.</description>
<link>http://www.nature.com/ncpendmet/current_issue/</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>&#169; 2008 Nature Publishing Group</dc:rights>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:issn>1745-8366</prism:issn>
<prism:eIssn>1745-8374</prism:eIssn>
<prism:copyright>&#169; 2008 Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/ncpendmet_logo.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0889"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0873"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0874"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0875"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0876"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0877"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0878"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0879"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0880"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0881"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0882"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0883"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0884"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0885"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpneuro0814"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0865"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0867"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0866"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0868"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0864"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0893"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0869"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0870"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0894"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0896"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0886"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/ncpendmet0887"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/ncpendmet_logo.gif">
<title>Nature Clinical Practice Endocrinology &amp; Metabolism</title>
<url>http://www.nature.com/includes/rj_globnavimages/ncpendmet_logo.gif</url>
<link>http://www.nature.com/ncpendmet/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0889">
<title>Gastric banding to treat obesity: band-aid or breakthrough?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0889</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Gastric banding to treat obesity: band-aid or breakthrough?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 421 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0889">doi:10.1038/ncpendmet0889</a>
</p>
<p>Authors: Kenneth S Polonsky
&amp; Samuel Klein</p>
]]></content:encoded>
<dc:title>Gastric banding to treat obesity: band-aid or breakthrough?</dc:title>
<dc:creator>Kenneth S Polonsky</dc:creator>
<dc:creator>Samuel Klein</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0889</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 421 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Editorial</prism:section>
<prism:startingPage>421</prism:startingPage>
<prism:endingPage>421</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0873">
<title>Serum adiponectin levels predict progression from diabetic nephropathy to ESRD</title>
<link>http://dx.doi.org/10.1038/ncpendmet0873</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Serum adiponectin levels predict progression from diabetic nephropathy to ESRD</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 422 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0873">doi:10.1038/ncpendmet0873</a>
</p>
]]></content:encoded>
<dc:title>Serum adiponectin levels predict progression from diabetic nephropathy to ESRD</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0873</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 422 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>422</prism:startingPage>
<prism:endingPage>422</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0874">
<title>Hyperthyroidism linked with increased ectopic supraventricular heart activity</title>
<link>http://dx.doi.org/10.1038/ncpendmet0874</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Hyperthyroidism linked with increased ectopic supraventricular heart activity</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 422 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0874">doi:10.1038/ncpendmet0874</a>
</p>
]]></content:encoded>
<dc:title>Hyperthyroidism linked with increased ectopic supraventricular heart activity</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0874</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 422 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>422</prism:startingPage>
<prism:endingPage>422</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0875">
<title>LRP5 polymorphisms influence BMD and fracture risk</title>
<link>http://dx.doi.org/10.1038/ncpendmet0875</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>LRP5 polymorphisms influence BMD and fracture risk</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 422 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0875">doi:10.1038/ncpendmet0875</a>
</p>
]]></content:encoded>
<dc:title>LRP5 polymorphisms influence BMD and fracture risk</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0875</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 422 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>422</prism:startingPage>
<prism:endingPage>423</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0876">
<title>Effects of growth hormone therapy in children with PWS</title>
<link>http://dx.doi.org/10.1038/ncpendmet0876</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Effects of growth hormone therapy in children with PWS</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 423 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0876">doi:10.1038/ncpendmet0876</a>
</p>
]]></content:encoded>
<dc:title>Effects of growth hormone therapy in children with PWS</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0876</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 423 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>423</prism:startingPage>
<prism:endingPage>423</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0877">
<title>Beneficial effects of GHRT in women with hypopituitarism</title>
<link>http://dx.doi.org/10.1038/ncpendmet0877</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Beneficial effects of GHRT in women with hypopituitarism</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 423 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0877">doi:10.1038/ncpendmet0877</a>
</p>
]]></content:encoded>
<dc:title>Beneficial effects of GHRT in women with hypopituitarism</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0877</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 423 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>423</prism:startingPage>
<prism:endingPage>424</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0878">
<title>Use of both IGF and collagen markers could improve detection of GH abuse</title>
<link>http://dx.doi.org/10.1038/ncpendmet0878</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Use of both IGF and collagen markers could improve detection of GH abuse</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 424 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0878">doi:10.1038/ncpendmet0878</a>
</p>
]]></content:encoded>
<dc:title>Use of both IGF and collagen markers could improve detection of GH abuse</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0878</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 424 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>424</prism:startingPage>
<prism:endingPage>424</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0879">
<title>Different vitamin D therapeutic regimens are equally effective in young children</title>
<link>http://dx.doi.org/10.1038/ncpendmet0879</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Different vitamin D therapeutic regimens are equally effective in young children</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 424 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0879">doi:10.1038/ncpendmet0879</a>
</p>
]]></content:encoded>
<dc:title>Different vitamin D therapeutic regimens are equally effective in young children</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0879</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 424 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>424</prism:startingPage>
<prism:endingPage>424</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0880">
<title>T3 thyrotoxicosis in patients with massively metastatic thyroid carcinoma</title>
<link>http://dx.doi.org/10.1038/ncpendmet0880</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>T3 thyrotoxicosis in patients with massively metastatic thyroid carcinoma</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 425 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0880">doi:10.1038/ncpendmet0880</a>
</p>
]]></content:encoded>
<dc:title>T3 thyrotoxicosis in patients with massively metastatic thyroid carcinoma</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0880</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 425 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>425</prism:startingPage>
<prism:endingPage>425</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0881">
<title>Effects of childhood exposure to Chernobyl fallout on thyroid function</title>
<link>http://dx.doi.org/10.1038/ncpendmet0881</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Effects of childhood exposure to Chernobyl fallout on thyroid function</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 425 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0881">doi:10.1038/ncpendmet0881</a>
</p>
]]></content:encoded>
<dc:title>Effects of childhood exposure to Chernobyl fallout on thyroid function</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0881</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 425 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>425</prism:startingPage>
<prism:endingPage>425</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0882">
<title>CKD severity in patients with diabetes affects the risk of foot ulcer</title>
<link>http://dx.doi.org/10.1038/ncpendmet0882</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>CKD severity in patients with diabetes affects the risk of foot ulcer</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 425 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0882">doi:10.1038/ncpendmet0882</a>
</p>
]]></content:encoded>
<dc:title>CKD severity in patients with diabetes affects the risk of foot ulcer</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0882</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 425 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>425</prism:startingPage>
<prism:endingPage>426</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0883">
<title>Effects of lowered LDL and blood pressure targets on atherosclerosis and CVD events</title>
<link>http://dx.doi.org/10.1038/ncpendmet0883</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Effects of lowered LDL and blood pressure targets on atherosclerosis and CVD events</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 426 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0883">doi:10.1038/ncpendmet0883</a>
</p>
]]></content:encoded>
<dc:title>Effects of lowered LDL and blood pressure targets on atherosclerosis and CVD events</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0883</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 426 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>426</prism:startingPage>
<prism:endingPage>426</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0884">
<title>Bisphosphonate use does not increase the risk of atrial fibrillation and flutter</title>
<link>http://dx.doi.org/10.1038/ncpendmet0884</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Bisphosphonate use does not increase the risk of atrial fibrillation and flutter</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 426 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0884">doi:10.1038/ncpendmet0884</a>
</p>
]]></content:encoded>
<dc:title>Bisphosphonate use does not increase the risk of atrial fibrillation and flutter</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0884</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 426 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>426</prism:startingPage>
<prism:endingPage>427</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0885">
<title>Effects of metformin or repaglinide therapy for diabetes on serum markers for CVD</title>
<link>http://dx.doi.org/10.1038/ncpendmet0885</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Effects of metformin or repaglinide therapy for diabetes on serum markers for CVD</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 427 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0885">doi:10.1038/ncpendmet0885</a>
</p>
]]></content:encoded>
<dc:title>Effects of metformin or repaglinide therapy for diabetes on serum markers for CVD</dc:title>
<dc:identifier>doi:10.1038/ncpendmet0885</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 427 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>427</prism:startingPage>
<prism:endingPage>427</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpneuro0814">
<title>Central obesity in middle age increases the risk of dementia later in life</title>
<link>http://dx.doi.org/10.1038/ncpneuro0814</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Central obesity in middle age increases the risk of dementia later in life</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 427 (2008). <a href="http://dx.doi.org/10.1038/ncpneuro0814">doi:10.1038/ncpneuro0814</a>
</p>
]]></content:encoded>
<dc:title>Central obesity in middle age increases the risk of dementia later in life</dc:title>
<dc:identifier>doi:10.1038/ncpneuro0814</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 427 (2008)</dc:source>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>427</prism:startingPage>
<prism:endingPage>427</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0865">
<title>Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0865</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 428 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0865">doi:10.1038/ncpendmet0865</a>
</p>
<p>Authors: Joshua Klopper
&amp; Bryan Haugen</p>
]]></content:encoded>
<dc:title>Can calcitonin and carcinoembryonic antigen doubling times predict progression of thyroid carcinoma?</dc:title>
<dc:creator>Joshua Klopper</dc:creator>
<dc:creator>Bryan Haugen</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0865</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 428 (2008)</dc:source>
<dc:date>2008-06-10</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-10</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Practice Point</prism:section>
<prism:startingPage>428</prism:startingPage>
<prism:endingPage>429</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0867">
<title>Dietary glycemic index and glycemic load in diabetes prevention&#8212;what can we learn from observational studies?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0867</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Dietary glycemic index and glycemic load in diabetes prevention&#8212;what can we learn from observational studies?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 430 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0867">doi:10.1038/ncpendmet0867</a>
</p>
<p>Author: Mark A Pereira</p>
]]></content:encoded>
<dc:title>Dietary glycemic index and glycemic load in diabetes prevention&#8212;what can we learn from observational studies?</dc:title>
<dc:creator>Mark A Pereira</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0867</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 430 (2008)</dc:source>
<dc:date>2008-06-10</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-10</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Practice Point</prism:section>
<prism:startingPage>430</prism:startingPage>
<prism:endingPage>431</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0866">
<title>Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0866</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 432 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0866">doi:10.1038/ncpendmet0866</a>
</p>
<p>Author: Jan Zedenius</p>
]]></content:encoded>
<dc:title>Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma?</dc:title>
<dc:creator>Jan Zedenius</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0866</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 432 (2008)</dc:source>
<dc:date>2008-06-10</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-10</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Practice Point</prism:section>
<prism:startingPage>432</prism:startingPage>
<prism:endingPage>433</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0868">
<title>Does an intensive multifactorial intervention reduce mortality in type 2 diabetes mellitus?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0868</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Does an intensive multifactorial intervention reduce mortality in type 2 diabetes mellitus?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 434 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0868">doi:10.1038/ncpendmet0868</a>
</p>
<p>Author: Bernard Zinman</p>
]]></content:encoded>
<dc:title>Does an intensive multifactorial intervention reduce mortality in type 2 diabetes mellitus?</dc:title>
<dc:creator>Bernard Zinman</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0868</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 434 (2008)</dc:source>
<dc:date>2008-06-24</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-24</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Practice Point</prism:section>
<prism:startingPage>434</prism:startingPage>
<prism:endingPage>435</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0864">
<title>Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancer</title>
<link>http://dx.doi.org/10.1038/ncpendmet0864</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancer</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 436 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0864">doi:10.1038/ncpendmet0864</a>
</p>
<p>Author: Sophie Leboulleux</p>
]]></content:encoded>
<dc:title>Prognostic role of undetectable ablation thyroglobulin and follow-up thyroglobulin in patients with thyroid cancer</dc:title>
<dc:creator>Sophie Leboulleux</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0864</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 436 (2008)</dc:source>
<dc:date>2008-06-24</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-24</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Practice Point</prism:section>
<prism:startingPage>436</prism:startingPage>
<prism:endingPage>437</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0893">
<title>The cutting edge in diabetes treatment&#8212;is weight-loss surgery an effective therapeutic strategy?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0893</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>The cutting edge in diabetes treatment&#8212;is weight-loss surgery an effective therapeutic strategy?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 438 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0893">doi:10.1038/ncpendmet0893</a>
</p>
<p>Authors: Lee M Kaplan
&amp; Nadia N Ahmad</p>
]]></content:encoded>
<dc:title>The cutting edge in diabetes treatment&#8212;is weight-loss surgery an effective therapeutic strategy?</dc:title>
<dc:creator>Lee M Kaplan</dc:creator>
<dc:creator>Nadia N Ahmad</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0893</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 438 (2008)</dc:source>
<dc:date>2008-07-01</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-07-01</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Practice Point</prism:section>
<prism:startingPage>438</prism:startingPage>
<prism:endingPage>439</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0869">
<title>Are prescribing patterns of antidiabetic medications influenced by fears of litigation?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0869</link>
<description>Management of diabetes mellitus is occasionally confounded by lack of understanding on the part of physicians and patients of issues surrounding the risks and benefits of antidiabetic drugs. The need for adequately powered outcome studies that minimize the effects of the unknown on prescribing habits in diabetes care is debated.</description>
<content:encoded><![CDATA[

<p>
<b>Are prescribing patterns of antidiabetic medications influenced by fears of litigation?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 440 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0869">doi:10.1038/ncpendmet0869</a>
</p>
<p>Author: John B Buse</p>
]]></content:encoded>
<dc:title>Are prescribing patterns of antidiabetic medications influenced by fears of litigation?</dc:title>
<dc:creator>John B Buse</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0869</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 440 (2008)</dc:source>
<dc:date>2008-06-17</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-17</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Viewpoint</prism:section>
<prism:startingPage>440</prism:startingPage>
<prism:endingPage>441</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0870">
<title>Dehydroepiandrosterone replacement therapy&#8212;panacea, snake oil, or a bit of both?</title>
<link>http://dx.doi.org/10.1038/ncpendmet0870</link>
<description>Age-related declines in dehydroepiandrosterone sulfate concentration parallel the physical and cognitive changes of aging. This observation suggests that these events are causally related and that replacement therapy might have beneficial effects in the elderly. The authors of this Viewpoint consider the evidence for, and against, such an approach.</description>
<content:encoded><![CDATA[

<p>
<b>Dehydroepiandrosterone replacement therapy&#8212;panacea, snake oil, or a bit of both?</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 442 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0870">doi:10.1038/ncpendmet0870</a>
</p>
<p>Authors: Alice Y Chang, Hans K Ghayee
&amp; Richard J Auchus</p>
]]></content:encoded>
<dc:title>Dehydroepiandrosterone replacement therapy&#8212;panacea, snake oil, or a bit of both?</dc:title>
<dc:creator>Alice Y Chang</dc:creator>
<dc:creator>Hans K Ghayee</dc:creator>
<dc:creator>Richard J Auchus</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0870</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 442 (2008)</dc:source>
<dc:date>2008-06-17</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-17</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Viewpoint</prism:section>
<prism:startingPage>442</prism:startingPage>
<prism:endingPage>443</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0894">
<title>The pathogenesis of diabetic nephropathy</title>
<link>http://dx.doi.org/10.1038/ncpendmet0894</link>
<description>Between 20% and 40% of patients with diabetes ultimately develop nephropathy. The bank of data on the multiple and complex mechanisms, disease markers and disease progression continues to grow. This article provides an overview of the current status of findings relating to underlying mechanisms and genetic susceptibility.</description>
<content:encoded><![CDATA[

<p>
<b>The pathogenesis of diabetic nephropathy</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 444 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0894">doi:10.1038/ncpendmet0894</a>
</p>
<p>Authors: Suma Dronavalli, Irena Duka
&amp; George L Bakris</p>
]]></content:encoded>
<dc:title>The pathogenesis of diabetic nephropathy</dc:title>
<dc:creator>Suma Dronavalli</dc:creator>
<dc:creator>Irena Duka</dc:creator>
<dc:creator>George L Bakris</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0894</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 444 (2008)</dc:source>
<dc:date>2008-07-08</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-07-08</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>444</prism:startingPage>
<prism:endingPage>452</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0896">
<title>Environmental factors and autoimmune thyroiditis</title>
<link>http://dx.doi.org/10.1038/ncpendmet0896</link>
<description>Autoimmune thyroiditis, which manifests as Hashimoto thyroiditis and Graves disease among other forms, is an inflammatory disorder of the thyroid gland. Various environmental factors interact with susceptibility genes and seem to be associated with disease initiation and to influence duration and severity. This Review summarizes the currently available information and highlights the areas that urgently require further study.</description>
<content:encoded><![CDATA[

<p>
<b>Environmental factors and autoimmune thyroiditis</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 454 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0896">doi:10.1038/ncpendmet0896</a>
</p>
<p>Author: Leonidas H Duntas</p>
]]></content:encoded>
<dc:title>Environmental factors and autoimmune thyroiditis</dc:title>
<dc:creator>Leonidas H Duntas</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0896</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 454 (2008)</dc:source>
<dc:date>2008-07-08</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-07-08</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>454</prism:startingPage>
<prism:endingPage>460</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0886">
<title>Techniques to quantify TSH receptor antibodies</title>
<link>http://dx.doi.org/10.1038/ncpendmet0886</link>
<description>Thyroid stimulation in Graves disease is caused by antibodies to the TSH receptor that have thyroid-stimulating or thyroid-blocking activity. Antibody detection can aid diagnosis and prediction of outcomes of the disease, as well as prediction of the course of associated ophthalmology. In this Review, Ajjan and Weetman describe the different measurement techniques available and their clinical applications.</description>
<content:encoded><![CDATA[

<p>
<b>Techniques to quantify TSH receptor antibodies</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 461 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0886">doi:10.1038/ncpendmet0886</a>
</p>
<p>Authors: RA Ajjan
&amp; AP Weetman</p>
]]></content:encoded>
<dc:title>Techniques to quantify TSH receptor antibodies</dc:title>
<dc:creator>RA Ajjan</dc:creator>
<dc:creator>AP Weetman</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0886</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 461 (2008)</dc:source>
<dc:date>2008-06-24</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-24</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>461</prism:startingPage>
<prism:endingPage>468</prism:endingPage>
</item>
<item rdf:about="http://dx.doi.org/10.1038/ncpendmet0887">
<title>Malignant struma ovarii</title>
<link>http://dx.doi.org/10.1038/ncpendmet0887</link>
<description>Struma ovarii is a rare tumor, characterized by the presence of thyroid tissue in an ovarian teratoma. In this article Yassa  et al. describe a patient who presented to her gynecologist with a pelvic mass, which was found to be a malignant struma ovarii. The investigations and treatment options for this tumor are described.</description>
<content:encoded><![CDATA[

<p>
<b>Malignant struma ovarii</b>
</p>
<p>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 469 (2008). <a href="http://dx.doi.org/10.1038/ncpendmet0887">doi:10.1038/ncpendmet0887</a>
</p>
<p>Authors: Leila Yassa, Peter Sadow
&amp; Ellen Marqusee</p>
]]></content:encoded>
<dc:title>Malignant struma ovarii</dc:title>
<dc:creator>Leila Yassa</dc:creator>
<dc:creator>Peter Sadow</dc:creator>
<dc:creator>Ellen Marqusee</dc:creator>
<dc:identifier>doi:10.1038/ncpendmet0887</dc:identifier>
<dc:source>Nature Clinical Practice Endocrinology &amp; Metabolism 4, 469 (2008)</dc:source>
<dc:date>2008-06-17</dc:date>
<prism:publicationName>Nature Clinical Practice Endocrinology &amp; Metabolism</prism:publicationName>
<prism:publicationDate>2008-06-17</prism:publicationDate>
<prism:volume>4</prism:volume>
<prism:number>8</prism:number>
<prism:section>Case Study</prism:section>
<prism:startingPage>469</prism:startingPage>
<prism:endingPage>472</prism:endingPage>
</item>
</rdf:RDF>
